Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Using intermittent theta burst stimulation to maintain depression treatment

Official title: Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression

Run by University of Regensburg · NCT05732311 · Data updated 2026-11-12

This study is testing whether giving people with depression who have benefited from a specific brain stimulation treatment either once a week or all at once can help them stay feeling better.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Regensburg
Academic / other
Locations1 site (Regensburg)
StatusRecruiting
StartedApril 25, 2023
Main results expectedJanuary 31, 2026
Study endsFebruary 28, 2026
Registry record updatedDecember 1, 2025
Trial IDNCT05732311 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 70 with a diagnosis of a depressive episode, recurrent depressive disorder, or bipolar disorder who have responded positively to prior iTBS treatment.

Probably not a fit

Patients with severe neurological diseases or those with contraindications for TMS, such as electrical implants, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves a randomized, multi-center, open-label approach where patients with depression who previously responded to intermittent theta burst stimulation (iTBS) will receive this treatment as maintenance therapy. Participants will be divided into two groups based on the frequency of stimulation: one group will receive standard iTBS over a week, while the other will receive accelerated iTBS in one day. An interim analysis will be conducted after half of the patients have been treated to estimate the effect size.

Why it matters

Potential benefit: If successful, this approach could provide a novel maintenance therapy option for patients with depression, potentially improving their long-term outcomes.

How similar studies have gone: While the use of iTBS has shown promise in treating depression, this specific approach as maintenance therapy is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adult women and men aged 18 to 70 years with an ICD-10 diagnosis of a depressive episode of depressive disorder (F32), recurrent depressive disorder (F33), or bipolar disorder (F31)
* moderate or severe current episode prior to initial open iTBS treatment (HAMD-21 \>16 points)
* response to iTBS treatment (either reduction in HAMD score by 50% or score at the end of treatment \<11 points)
* no concomitant psychotic symptoms.
* no other relevant psychiatric disorder as assessed by the study physician
* residence in Germany and German speaking that allows understanding of the information provided
* patient is capable of giving consent

Exclusion Criteria:

* fulfillment of the general contraindications for TMS (electrical implants or metallic objects in the body such as pacemakers or insulin pumps).
* severe neurological diseases (e.g., cerebrovascular events, neurodegenerative diseases, epilepsy, malformations of the brain, severe head injury in the history)
* current harmful use or dependence on alcohol, amphetamines, cocaine, benzodiazepines, anticonvulsants, or opiates
* acute suicidality
* pregnancy
* current participation in another study

Where it's running

  • Department of Psychiatry and Psychotherapy, University of Regensburg
    Regensburg, Germany
    Recruiting

Study contacts

  • Principal investigator: Berthold Langguth, Prof. — University Hospital of Regensburg, Department of Psychiatry and Psychotherapy at the Bezirksklinikum
  • Study coordinator: Martin Schecklmann, Prof.
  • Email: martin.schecklmann@medbo.de
  • Phone: +49-941-941-2054

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.